Terms: = Pancreatic cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
26 results:
1. Synchronous detection of pancreatic adenocarcinoma and paraganglioma in a Whipple resection specimen.
Aaquist T; Dembic M; Thomassen M; de Stricker K; Bertelsen M; Christensen LG; Mortensen MB; Detlefsen S
Pathol Res Pract; 2021 Oct; 226():153590. PubMed ID: 34454393
[TBL] [Abstract] [Full Text] [Related]
2. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract] [Full Text] [Related]
3. fhit down-regulation is an early event in pancreatic carcinogenesis.
Fassan M; Rusev B; Corbo V; Gasparini P; Luchini C; Vicentini C; Mafficini A; Paiella S; Salvia R; Cataldo I; Scarpa A; Huebner K
Virchows Arch; 2017 Jun; 470(6):647-653. PubMed ID: 28289900
[TBL] [Abstract] [Full Text] [Related]
4. Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before Liver Transplantation.
Alotaibi F; Kabbani M; Abaalkhail F; Chorley A; Elbeshbeshy H; Al-Hamoudi W; Alabbad S; Boehnert MU; Alsofayan M; Al-Kattan W; Ahmed B; Broering D; Al Sebayel M; Elsiesy H
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):37-41. PubMed ID: 28260429
[TBL] [Abstract] [Full Text] [Related]
5. Integrated Genomic Analysis of pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease.
Murphy SJ; Hart SN; Halling GC; Johnson SH; Smadbeck JB; Drucker T; Lima JF; Rohakhtar FR; Harris FR; Kosari F; Subramanian S; Petersen GM; Wiltshire TD; Kipp BR; Truty MJ; McWilliams RR; Couch FJ; Vasmatzis G
Cancer Res; 2016 Feb; 76(3):749-61. PubMed ID: 26676757
[TBL] [Abstract] [Full Text] [Related]
6. Fragile histidine triad (fhit) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathway.
Huang Q; Liu Z; Xie F; Liu C; Shao F; Zhu CL; Hu S
ScientificWorldJournal; 2014; 2014():179698. PubMed ID: 24757411
[TBL] [Abstract] [Full Text] [Related]
7. [Incidence and mortality of cancer in Zhejiang province in 2009].
Li HZ; Mao WM; Wang XH; Yu CD; Du LB
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jul; 47(7):592-6. PubMed ID: 24304949
[TBL] [Abstract] [Full Text] [Related]
8. Genome profiling of pancreatic adenocarcinoma.
Birnbaum DJ; Adélaïde J; Mamessier E; Finetti P; Lagarde A; Monges G; Viret F; Gonçalvès A; Turrini O; Delpero JR; Iovanna J; Giovannini M; Birnbaum D; Chaffanet M
Genes Chromosomes Cancer; 2011 Jun; 50(6):456-65. PubMed ID: 21412932
[TBL] [Abstract] [Full Text] [Related]
9. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
[TBL] [Abstract] [Full Text] [Related]
10. [Gene methylation patterns in digestive tumors].
Roa S JC; García M P; Melo A A; Tapia E O; Villaseca H M; Araya O JC; Guzmán G P
Rev Med Chil; 2008 Apr; 136(4):451-8. PubMed ID: 18769787
[TBL] [Abstract] [Full Text] [Related]
11. Molecular aspects of carcinogenesis in pancreatic cancer.
Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
[TBL] [Abstract] [Full Text] [Related]
12. Copy-number variants in patients with a strong family history of pancreatic cancer.
Lucito R; Suresh S; Walter K; Pandey A; Lakshmi B; Krasnitz A; Sebat J; Wigler M; Klein AP; Brune K; Palmisano E; Maitra A; Goggins M; Hruban RH
Cancer Biol Ther; 2007 Oct; 6(10):1592-9. PubMed ID: 17912030
[TBL] [Abstract] [Full Text] [Related]
13. Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion.
Sorio C; Capelli P; Lissandrini D; Moore PS; Balzarini P; Falconi M; Zamboni G; Scarpa A
Virchows Arch; 2005 Mar; 446(3):239-45. PubMed ID: 15688169
[TBL] [Abstract] [Full Text] [Related]
14. Chromosome arm 8p and cancer: a fragile hypothesis.
Birnbaum D; Adélaïde J; Popovici C; Charafe-Jauffret E; Mozziconacci MJ; Chaffanet M
Lancet Oncol; 2003 Oct; 4(10):639-42. PubMed ID: 14554243
[TBL] [Abstract] [Full Text] [Related]
15. Effect of fhit gene replacement on growth, cell cycle and apoptosis in pancreatic cancer cells.
Gopalakrishnan VK; Banerjee AG; Vishwanatha JK
Pancreatology; 2003; 3(4):293-302. PubMed ID: 12890991
[TBL] [Abstract] [Full Text] [Related]
16. Alterations in the fhit gene in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.
Tsujiuchi T; Sasaki Y; Kubozoe T; Konishi Y; Tsutsumi M
Mol Carcinog; 2003 Feb; 36(2):60-6. PubMed ID: 12557261
[TBL] [Abstract] [Full Text] [Related]
17. Genetic abnormalities in pancreatic cancer.
Moore PS; Beghelli S; Zamboni G; Scarpa A
Mol Cancer; 2003 Jan; 2():7. PubMed ID: 12537585
[TBL] [Abstract] [Full Text] [Related]
18. Papillary solid and cystic pancreatic tumor. Genetic prediction factors for malignancy: report of three cases.
Brozzetti S; French D; Polistena A; Di Marzo L; Pisani T; Marchese R; Mingazzini P; Mascioli G; Vecchione A; Cavallaro A
Anticancer Res; 2002; 22(4):2341-6. PubMed ID: 12174924
[TBL] [Abstract] [Full Text] [Related]
19. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
[TBL] [Abstract] [Full Text] [Related]
20. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.
Dumon KR; Ishii H; Vecchione A; Trapasso F; Baldassarre G; Chakrani F; Druck T; Rosato EF; Williams NN; Baffa R; During MJ; Huebner K; Croce CM
Cancer Res; 2001 Jun; 61(12):4827-36. PubMed ID: 11406559
[TBL] [Abstract] [Full Text] [Related]
[Next]
